Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience: SEK 3.8 mln grant for treatment against leukemia

Dec 10 (Reuters) - Sprint Bioscience AB  SPRINT.ST : 
    * Gets 3.8 million in Vinnova-grant for new treatment against leukemia 
    * Will use the grant to further develop PIP4K2a-project 
 
Source text for Eikon:  ID:nWkrli1501  
     
Further company coverage:  SPRINT.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Sprint Bioscience AB

See all news